|Articles|February 24, 2020
MALDI-DIT Analysis of Modification Site of Chemically Modified Antibody
Author(s)Shimadzu
This application note showcases the high MSn analysis capability of an ultra-compact MALDI digital ion trap (DIT) mass spectrometer, and its ability to obtain information from modified peptides.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
